Effect Study of Optimized Intervention to Heroin Addicts

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to explore barriers and determine whether optimizing protocol is effective in the treatment of heroin dependence in community-based MMT clinics.

Clinical Trial Description

Drug dependence is one of the most serious public health problems worldwide. In China, among more than 100, 0000 registered drug addicts mostly are heroin dependence. Drug dependence post great risks to physical condition, their family and society, and can lead to infectious disease transmission. Though almost 500 MMT clinics which can offer MMT service to heroin addicts have been set up, there are still some problems, for example, poor compliance, high rate of dropping out and relapse which affect the service delivery to them. The guideline developed by WHO focused on psychotherapy to opiate addicts with MMT. So delivery of a set of comprehensive, integrated psychotherapy to opiate addicts is very critical in such methadone clinics. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Heroin Dependence

Clinical Trial Details

NCT number	NCT01144390
Study type	Interventional
Source	Shanghai Mental Health Center
Contact
Status	Active, not recruiting
Phase	N/A
Start date	April 2010
Completion date	June 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00577408` - Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone	Phase 3
Completed	`NCT00218309` - Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals	Phase 2
Completed	`NCT00000210` - Treatment Efficacy for Drug Abuse and AIDS Prevention - 1	Phase 2
Completed	`NCT00000211` - Treatment Efficacy for Drug Abuse and AIDS Prevention - 2	Phase 2
Completed	`NCT02324725` - Biomarkers of Injectable Extended Release Naltrexone Treatment	Phase 4
Withdrawn	`NCT00000330` - Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5	Phase 2
Completed	`NCT00249457` - Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2	N/A
Completed	`NCT00218127` - Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens	Phase 2
Completed	`NCT04133974` - Methadone Induced Memory Retrieval-extinction Procedure in Heroin Addicts	N/A
Completed	`NCT00015288` - Buprenorphine and Naloxone Combination Study - 10	Phase 1
Terminated	`NCT03711318` - Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals	Phase 3
Recruiting	`NCT02541526` - Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia	Phase 3
Active, not recruiting	`NCT02541513` - An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence	Phase 3
Completed	`NCT01760473` - Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone	Phase 3
Terminated	`NCT01395797` - Pioglitazone for Heroin and for Nicotine Dependence	Phase 1/Phase 2
Completed	`NCT01668706` - Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid Addicts	N/A
Active, not recruiting	`NCT00609089` - Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction	Phase 1/Phase 2
Completed	`NCT00684840` - Effects of Stress and Other Factors on Opiate Drug Choice.	N/A
Completed	`NCT00759005` - Effect of Stress on Heroin-Related Memory Retrieval	N/A
Completed	`NCT00218530` - Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1	Phase 1